4-Tetrazol-1-yl-phenol, 95.0%, 1g

5-BROMO-2-METHYL-3-(PROPAN-2-YL)-2H-INDAZOLE, 95%, 100mg

(3R,5S,6E)-7-[4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-[(METHANESULFONYL) METHYLAMINO]PYRIMIDIN-5-YL]-3,5-DIHYDROXYHEPT-6-ENOIC ACID TERT-BUTYL ESTER, 95%, 5g

1-Methoxy-4-vinylbenzene, 95.0%, 1g

5,6-Dichloro-N-(2,4-dimethoxybenzyl)-N-(thiazol-2-yl)pyridine-3-sulfonamide, 95%, 250mg

4-Oxo-1,4-dihydroquinoline-3-carboxylic acid, 95.0%, 25g

2,4-Dichloro-6-methylpyrimidine-5-carbonitrile, 95.0%, 100mg

Phosphoenolpyruvic Acid Tris(cyclohexylammonium) Salt>98.0%(T)1g

4-Bromophenol>98.0%(GC)(T)100g

Dipropylene glycol monopropyl ether, min 98%, for synthesis, 1L, plastic packaging.

6-chloro-N~4~-methyl-2,4-pyrimidinediamine, 95.0%, 10g

Ethyl 3-chloro-5-methylpyrazine-2-carboxylate, 100mg

(R)-BoroLeu-(+)-Pinanediol trifluoroacetate, 95.0%, 5g